First Diagnosis of Atrial Fibrillation at the Time of Stroke

Cerebrovascular Diseases

Volumn 43, Issue 3-4, 2017, Pages 192-199

  Borowsky, Leila H ^a   Regan, Susan ^a,b   Chang, Yuchiao ^a,b   Ayres, Alison ^a   Greenberg, Steven M ^a,b   Singer, Daniel E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute stroke prevention; Anticoagulants; Atrial fibrillation; Clinical epidemiology; Ischemic stroke; Risk factors for stroke; Screening for atrial fibrillation

Indexed keywords

ANTICOAGULANT AGENT; CREATININE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHADS2 SCORE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HOLTER MONITORING; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; TELEMETRY; VERY ELDERLY; CEREBROVASCULAR ACCIDENT; COMPLICATION; DISABILITY; ELECTRONIC HEALTH RECORD; FACTUAL DATABASE; GENERAL HOSPITAL; HEART ATRIUM FLUTTER; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; REGISTER; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BOSTON; BRAIN ISCHEMIA; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISABILITY EVALUATION; ELECTROCARDIOGRAPHY; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, GENERAL; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TELEMETRY;

EID: 85013656427     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000457809     Document Type: Article

References (28)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham heart study. Arch Intern Med 1987; 147: 1561-1564.
2. Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
3. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM: Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983; 14: 664-667.
4. Shroff GR, Solid CA, Herzog CA: Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010. J Am Heart Assoc 2014; 3:e000756.
5. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D: 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet 2015; 386: 154-162.
6. Mann D, Reynolds K, Smith D, Muntner P: Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 national cholesterol education program guidelines. Ann Pharmacother 2008; 42: 1208-1215.
7. Gu Q, Burt VL, Dillon CF, Yoon S: Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010. Circulation 2012; 126: 2105-2114.
8. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955-962.
9. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
10. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
11. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG: Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
12. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864-2870.
13. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factorbased approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
14. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL: ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e257-e354.
15. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026.
16. Friberg L, Rosenqvist M, Lindgren A, Terent A, Norrving B, Asplund K: High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke 2014; 45: 2599-2605.
17. Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators: Causes of ischemic stroke in patients with non-valvular atrial fibrillation. Cerebrovasc Dis 2016; 42: 196-204.
18. Rho RW, Page RL: Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 2005; 48: 79-87.
19. Sposato LA, Cipriano LE, Saposnik G, Ruiz Vargas E, Riccio PM, Hachinski V: Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 377-387.
20. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M: Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 2013; 127: 930-937.
21. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, Raftery JP, Bryan S, Davies M, Lip GY, Allan TF: Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007; 335: 383.
22. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, Bennett AA, Briffa T, Bauman A, Martinez C, Wallenhorst C, Lau JK, Brieger DB, Sy RW, Freedman SB: Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost 2014; 111: 1167-1176.
23. Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M: Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 2015; 131: 2176-2184.
24. Schulman S, Cybulsky I, Delaney J: Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery. Thromb Res 2015; 135: 841-845.
25. Epstein AE, Alexander JC, Gutterman DD, Maisel W, Wharton JM; American College of Chest Physicians: Anticoagulation: American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128(2 suppl):24S-27S.
26. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ: Antithrombotic therapy in atrial fibrillation: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133(6 suppl):546S-592S.
27. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Society of Cardiovascular Anesthesiologists; Society of Thoracic Surgeons: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58:e123-e210.
28. Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW, Rahman F, Mc-Manus DD, Tadros TM, Levy D, Vasan RS, Larson MG, Ellinor PT, Benjamin EJ: Longterm outcomes of secondary atrial fibrillation in the community: the Framingham heart study. Circulation 2015; 131: 1648-1655.